Medicare GLP-1 Bridge statistics
The price, the covered products and the dates of the CMS GLP-1 Bridge, plus the figure nobody has published.
The numbers
- The CMS GLP-1 Bridge sets a flat $50 a month for qualifying Part D members. (CMS, September 28, 2026)
- 3 products are covered: Wegovy, Foundayo, the Zepbound KwikPen. The Zepbound vials do not qualify..
- The window opened July 1, 2026 and closes December 31, 2027.
- 10 of the 51 state Medicaid programs cover Wegovy for obesity on limited terms, a separate program the Bridge does not change. (GLP Chart Medicaid corpus, August 28, 2026)
Source: CMS, checked September 28, 2026, except where noted.
Not yet published
CMS has published no enrollment or uptake figure for the Bridge. When CMS publishes, the number lands here with its source.
The Bridge, term by term
| Measure | Value | Detail | Source |
|---|---|---|---|
| Flat monthly price | $50 | Part D members in one of three BMI bands. BMI 35 and over on its own. BMI 30 and over with heart failure with preserved ejection fraction, uncontrolled hypertension or CKD stage 3a and up. BMI 27 and over with pre-diabetes, a prior heart attack, a prior stroke or symptomatic peripheral artery disease. Prior authorization required. | CMS |
| Covered products | Wegovy, Foundayo, the Zepbound KwikPen | The Zepbound vials do not qualify. | CMS |
| Window opens | July 1, 2026 | Qualifying Part D members only | CMS |
| Window closes | December 31, 2027 | No renewal announced | CMS |
| Fill quantity | One monthly supply per fill | One fill = a single monthly supply of 28 or 30 days. CMS verbatim: 'Beneficiaries who are approved for coverage under the Medicare GLP-1 Bridge may obtain a single monthly supply (28 or 30 days) of an eligible GLP-1 product per fill. Sixty or ninety-day fills are not available.' Checked 2026-07-19 on the Information for Pharmacies page. | CMS |
| Low Income Subsidy | Does not reduce the price | No low-income subsidy on Bridge drugs. CMS verbatim: 'there is no low-income subsidy (LIS) provided for LIS beneficiaries'. Extra Help does NOT reduce the $50. Checked 2026-07-19 at cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge. | CMS |
Download this table: CSV or JSON. Free to reuse under CC BY 4.0 with a link. Nothing to sign up for.
Cite or embed this
Medicare GLP-1 Bridge statistics, GLP Chart, October 19, 2026. glpchart.com/stats/medicare-glp1-bridge-statistics/
<a href="https://glpchart.com/stats/medicare-glp1-bridge-statistics/">Medicare GLP-1 Bridge statistics</a>. Data: GLP Chart, October 19, 2026
Prices behind these figures are checked every Monday. The current numbers live on the price index, and the dated monthly release is the GLP-1 Cash Price Index, October 2026. For any other cut of the data, email press@glpchart.com and you will have it within 24 hours.
The other statistics pages
- GLP-1 prices by state. What the cheapest verified cash GLP-1 route costs in each US state, and which states have fewer programs to choose from.
- GLP-1 cash prices over time. Every month since the weekly record opened, with the compounded and branded floors beside it.
- GLP-1 insurance coverage by payer. How 21 US insurers treat GLP-1s across the payer policies GLP Chart has read.
- Medicaid GLP-1 coverage by state. What each state Medicaid program covers, read from its own preferred drug list.
- Compounded versus branded GLP-1 spread. The gap between the cheapest verified compounded route and the cheapest verified branded route, month by month.
- GLP-1 shortage history. What the FDA shortage database says about each GLP-1 molecule today.